AstraZeneca Financial Statements From 2010 to 2026

AstraZeneca PLC Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 119.8 B 114.1 B 73.1 B Slightly volatile Short and Long Term Debt Total 31.2 B 29.7 B 19.5 B Slightly volatile Total Current Liabilities 32.1 B 30.6 B 19.8 B Slightly volatile Total Stockholder Equity 51.1 B 48.7 B 25.6 B Slightly volatile Property Plant And Equipment Net 15.4 B 14.7 B 8.5 B Slightly volatile Net Debt 25.2 B 24 B 13.7 B Slightly volatile Accounts Payable 26.5 B 25.3 B 5.7 B Slightly volatile Cash 4.6 B 5.7 B 5.7 B Very volatile Non Current Assets Total 89.6 B 85.4 B 53.4 B Slightly volatile Cash And Short Term Investments 5.8 B 5.7 B 6.5 B Pretty Stable Common Stock Shares Outstanding 2.9 B 3.1 B 2.7 B Slightly volatile Short Term Investments 28.5 M 30 M 705.5 M Slightly volatile Liabilities And Stockholders Equity 119.8 B 114.1 B 73.1 B Slightly volatile Non Current Liabilities Total 36.5 B 34.7 B 27.3 B Slightly volatile Inventory 6.9 B 6.6 B 3.8 B Slightly volatile Other Current Assets 1.2 B 1.2 B 3 B Pretty Stable Total Liabilities 68.6 B 65.4 B 47 B Slightly volatile Total Current Assets 16.1 B 28.7 B 18.9 B Slightly volatile Short Term Debt 3.7 B 3.6 B 2.4 B Slightly volatile Other Current Liabilities 1.7 B 1.8 B 10.1 B Slightly volatile Net Receivables 15.9 B 15.2 B 7.1 B Slightly volatile Intangible Assets 39.7 B 37.8 B 25.9 B Slightly volatile Common Stock 298.1 M 349.2 M 332.8 M Slightly volatile Good Will 14 B 21.2 B 13.5 B Slightly volatile Long Term Debt 19.9 B 24.7 B 26.7 B Slightly volatile Capital Lease Obligations 1.4 B 1.8 B 1.1 B Slightly volatile Net Invested Capital 76.2 B 76.5 B 69.5 B Slightly volatile Property Plant And Equipment Gross 14.4 B 14.7 B 18.1 B Slightly volatile Short and Long Term Debt 3.7 B 3.1 B 2.2 B Slightly volatile Capital Stock 426.4 M 446.2 M 392.9 M Slightly volatile Other Assets 5.4 B 6.8 B 4.1 B Slightly volatile Long Term Debt Total 27.3 B 31.8 B 24.6 B Slightly volatile Capital Surpluse 38.7 B 40.5 B 35.7 B Slightly volatile Cash And Equivalents 3.6 B 3.8 B 4.6 B Slightly volatile Property Plant Equipment 11.6 B 13.4 B 10 B Slightly volatile
AstraZeneca PLC Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 6 B 5.7 B 3.7 B Slightly volatile Interest Expense 862.7 M 1.7 B 1.1 B Slightly volatile Total Revenue 61.7 B 58.7 B 33.3 B Slightly volatile Other Operating Expenses 47.2 B 45 B 27.3 B Slightly volatile Operating Income 14.4 B 13.7 B 6.1 B Slightly volatile EBIT 14.8 B 14.1 B 6.2 B Slightly volatile Research Development 14.9 B 14.2 B 7.7 B Slightly volatile EBITDA 20.8 B 19.8 B 9.9 B Slightly volatile Total Operating Expenses 36.1 B 34.4 B 20.4 B Slightly volatile Net Income 10.8 B 10.3 B 4.3 B Slightly volatile Selling General Administrative 12.1 B 19.9 B 13.3 B Slightly volatile Gross Profit 24.7 B 48.1 B 25.1 B Slightly volatile Cost Of Revenue 6.7 B 10.6 B 6.7 B Slightly volatile Selling And Marketing Expenses 550 M 579 M 3 B Very volatile Interest Income 248.6 M 360 M 108.9 M Slightly volatile Net Income From Continuing Ops 5.9 B 10.2 B 2 B Slightly volatile Reconciled Depreciation 5.5 B 5.7 B 4.5 B Slightly volatile Net Income Applicable To Common Shares 8.5 B 10.2 B 6.4 B Slightly volatile
AstraZeneca PLC Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Free Cash Flow 12.4 B 11.8 B 4.5 B Slightly volatile Begin Period Cash Flow 4.5 B 5.4 B 5.9 B Pretty Stable Depreciation 6 B 5.7 B 3.9 B Slightly volatile Capital Expenditures 2.1 B 2.8 B 2.5 B Slightly volatile Total Cash From Operating Activities 15.3 B 14.6 B 7 B Slightly volatile End Period Cash Flow 4.2 B 5.7 B 5.6 B Very volatile Dividends Paid 3.6 B 5.1 B 3.7 B Slightly volatile Stock Based Compensation 516.8 M 665.9 M 378.9 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 4.65 4.8963 10.3642 Slightly volatile Dividend Yield 0.0218 0.0173 0.0328 Slightly volatile PTB Ratio 5.61 5.9096 91.2117 Slightly volatile Days Sales Outstanding 98.93 102 92.1463 Slightly volatile Book Value Per Share 33.0 31.4316 18.4699 Slightly volatile Free Cash Flow Yield 0.0276 0.0301 0.0314 Slightly volatile Operating Cash Flow Per Share 9.87 9.4032 4.9831 Slightly volatile Average Payables 1.3 B 2.4 B 2.5 B Very volatile Stock Based Compensation To Revenue 0.0101 0.0112 0.0113 Slightly volatile Capex To Depreciation 1.3 1.03 0.8572 Pretty Stable PB Ratio 5.61 5.9096 91.2117 Slightly volatile EV To Sales 5.04 5.3033 10.7747 Slightly volatile Free Cash Flow Per Share 5.87 5.5935 2.8733 Slightly volatile Inventory Turnover 2.88 1.6216 2.5231 Slightly volatile Net Income Per Share 6.93 6.5968 3.0711 Slightly volatile Days Of Inventory On Hand 122 225 155 Slightly volatile Payables Turnover 0.4 0.4206 2.7655 Pretty Stable Sales General And Administrative To Revenue 0.28 0.31 0.3339 Slightly volatile Average Inventory 1.4 B 1.4 B 1.2 B Slightly volatile Research And Ddevelopement To Revenue 0.14 0.2423 0.2 Slightly volatile Capex To Revenue 0.0642 0.1005 0.0859 Pretty Stable Cash Per Share 3.04 3.7039 4.7052 Slightly volatile POCF Ratio 18.75 19.7326 80.9755 Slightly volatile Interest Coverage 7.71 8.1128 8.8779 Slightly volatile Payout Ratio 0.46 0.4862 3.1222 Pretty Stable Capex To Operating Cash Flow 0.67 0.4051 0.4924 Very volatile PFCF Ratio 31.51 33.1721 238 Slightly volatile Days Payables Outstanding 911 868 241 Slightly volatile ROE 0.33 0.2101 0.2128 Slightly volatile EV To Operating Cash Flow 20.3 21.3731 83.4239 Slightly volatile PE Ratio 26.72 28.1274 237 Pretty Stable Return On Tangible Assets 0.11 0.186 0.1179 Pretty Stable EV To Free Cash Flow 34.13 35.93 244 Slightly volatile Earnings Yield 0.0341 0.0356 0.037 Slightly volatile Intangibles To Total Assets 0.27 0.518 0.4939 Slightly volatile Net Debt To EBITDA 0.82 1.2059 1.7771 Slightly volatile Current Ratio 1.49 0.9381 1.1169 Slightly volatile Receivables Turnover 4.65 3.5946 4.0969 Slightly volatile Graham Number 71.68 68.2666 33.3501 Slightly volatile Shareholders Equity Per Share 32.97 31.3981 18.1286 Slightly volatile Debt To Equity 0.58 0.6087 1.1476 Slightly volatile Capex Per Share 4.0 3.8097 2.1098 Slightly volatile Average Receivables 1.7 B 3 B 3.1 B Very volatile Revenue Per Share 39.79 37.8961 23.9166 Slightly volatile Interest Debt Per Share 21.21 20.2039 14.5748 Slightly volatile Debt To Assets 0.17 0.2597 0.2718 Pretty Stable Enterprise Value Over EBITDA 14.92 15.71 52.883 Slightly volatile Short Term Coverage Ratios 4.46 4.6956 3.4508 Pretty Stable Price Earnings Ratio 26.72 28.1274 237 Pretty Stable Operating Cycle 343 327 242 Slightly volatile Price Book Value Ratio 5.61 5.9096 91.2117 Slightly volatile Days Of Payables Outstanding 911 868 241 Slightly volatile Dividend Payout Ratio 0.46 0.4862 3.1222 Pretty Stable Price To Operating Cash Flows Ratio 18.75 19.7326 80.9755 Slightly volatile Price To Free Cash Flows Ratio 31.51 33.1721 238 Slightly volatile Operating Profit Margin 0.16 0.234 0.1802 Slightly volatile Company Equity Multiplier 2.23 2.344 3.5945 Slightly volatile Long Term Debt To Capitalization 0.26 0.3368 0.4228 Pretty Stable Total Debt To Capitalization 0.28 0.3784 0.4571 Pretty Stable Return On Capital Employed 0.24 0.1647 0.1349 Slightly volatile Debt Equity Ratio 0.58 0.6087 1.1476 Slightly volatile Ebit Per Revenue 0.16 0.234 0.1802 Slightly volatile Quick Ratio 1.18 0.724 0.8936 Slightly volatile Dividend Paid And Capex Coverage Ratio 1.32 1.3401 1.04 Very volatile Cash Ratio 0.25 0.1865 0.3075 Slightly volatile Operating Cash Flow Sales Ratio 0.14 0.2481 0.1918 Very volatile Days Of Inventory Outstanding 122 225 155 Slightly volatile Days Of Sales Outstanding 98.93 102 92.1463 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 0.31 0.5949 0.5064 Very volatile Cash Flow Coverage Ratios 0.47 0.492 0.3861 Slightly volatile Price To Book Ratio 5.61 5.9096 91.2117 Slightly volatile Fixed Asset Turnover 2.76 3.995 3.8022 Pretty Stable Capital Expenditure Coverage Ratio 2.23 2.4682 2.4639 Very volatile Price Cash Flow Ratio 18.75 19.7326 80.9755 Slightly volatile Enterprise Value Multiple 14.92 15.71 52.883 Slightly volatile Debt Ratio 0.17 0.2597 0.2718 Pretty Stable Cash Flow To Debt Ratio 0.47 0.492 0.3861 Slightly volatile Price Sales Ratio 4.65 4.8963 10.3642 Slightly volatile Return On Assets 0.1 0.0896 0.0613 Pretty Stable Asset Turnover 0.78 0.5149 0.5077 Pretty Stable Net Profit Margin 0.1 0.1741 0.1179 Pretty Stable Gross Profit Margin 0.83 0.819 0.7417 Very volatile Price Fair Value 5.61 5.9096 91.2117 Slightly volatile Return On Equity 0.33 0.2101 0.2128 Slightly volatile
AstraZeneca PLC Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 253.6 B 242.4 B 176.7 B Very volatile Enterprise Value 268.5 B 268.4 B 190 B Very volatile

AstraZeneca Fundamental Market Drivers

AstraZeneca Upcoming Events

About AstraZeneca PLC Financial Statements

Pair Trading with AstraZeneca PLC

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AstraZeneca PLC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will appreciate offsetting losses from the drop in the long position's value.When determining whether AstraZeneca PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AstraZeneca PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrazeneca Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrazeneca Plc Stock:

How To Invest In AstraZeneca Details

Is AstraZeneca Stock a good investment? Details

What is AstraZeneca PLC's Net Worth? Details

Largest Pharmaceuticals Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details